Summary The provision of care for patients with epilepsy in the UK is fragmented and inadequate. Lack of support in the community, poor communication across the primary-secondary care interface and inaccessibility of specialist services are contributory factors. The inclusion of epilepsy as a quality marker in the new general practitioner (GP) contract provides an opportunity to improve co-ordination of services.
Introduction
Epilepsy is the commonest chronic neurological disorder seen in primary care. All existing recommendations, including the recent CSAG report, 1 emphasise the role of the general practitioner (GP) in the delivery of care to patients with epilepsy. Indeed a key element of family practice, registration with a specific doctor, should ensure the continuity of that care.
While it may be difficult to directly relate the process of care to overall patient outcome 2 there are powerful arguments for the regular review of, and hazards of failure to review, individual patients. This applies to both refractory epilepsy where the diagnosis may be incorrect 3 or where patients may benefit from newer therapies 4 and epilepsy in remission where statutory regulations may change 5 and where long-term treatment may not be necessary. 6 Furthermore, all patients deserve to be informed about new knowledge concerning the risks of treatment, e.g. vigabatrin retinopathy, 7 or fetal valproate syndrome. 8 Historically review arrangements in primary care have consistently been reported to be inadequate. 1, 9 While there are instances of effective change, 10, 11 there has been no systematic attempt by primary care to improve its contribution to the quality of care of patients with epilepsy. This has become a topical issue because of the putative association between epilepsy-related death and quality of care. 12 Furthermore, the forthcoming national service framework (NSF) for chronic disease will define standards of care for patients with epilepsy and, indeed, the New GP Contract 13 highlights four quality outcome measures each carrying a minimum standard of attainment of 25% (Table 1) . For a practice to obtain maximum points, and hence full remuneration, they must reach the maximum threshold in each section documented below.
In anticipation of the need to improve services locally, the Chester City Primary Care Group (PCG) appointed a GP to conduct a comprehensive audit of the documented process of care of all patients with epilepsy registered in 13 practices serving the city of Chester, funded through SPREAD (Stimulating Primary Care Research and Development) monies. This short report discusses the preliminary findings and their implications.
Methods
The practice records of 610 patients with a diagnosis of epilepsy who were receiving repeat prescriptions for anti-epileptic drugs (AEDs) were reviewed. Information was collected using the paper notes and the 'Vampvision', 'EMIS' and 'Torex' GP computer operating systems in 1, 5 and 7 practices, respectively. teratogenic drugs. One cannot identify those patients who can be managed solely in the community and those who merit reassessment in hospital clinics. Assuming these findings are representative, primary and specialist secondary care face an enormous task in reorganising services to ensure that all patients receive appropriate care. This project describes a method of improving local co-ordination of patient care. # 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. In addition to simple demographic details, data collected included documented evidence about (a) diagnosis: when, by whom, and uncertainty. The latter was assessed from correspondence at the time of diagnosis, any doubt expressed in letters and the auditor's impression. (b) Follow-up arrangements; date of last review, review frequency, whether nominally receiving shared care. (c) Current condition: whether in remission, prescribed treatment, compliance. Compliance was evaluated on prescriptions collected in the previous 12 months. It was intended to collect information on seizure frequency, family history, employment, driving, side effects, free prescriptions and lifestyle issues. However, it became quite clear that this information was poorly documented and would be unavailable.
The intervention comprised a consultant-led tutorial on diagnosis and management, feedback on specific cases in each practice and, crucially, a computer-based template for each patient. This contained demographic and clinical details including results of investigations (EEG, imaging) and concluded with patient categorisation and management recommendations; diagnosis secure and management appropriate--annual review; epilepsy in remission--consider drug withdrawal; diagnostic uncertainty, women of child-bearing age and refractory epilepsy--consider referral for specialist assessment. It was then the responsibility of the individual GP/practice to review patients, document findings and decide on whether to intervene in the knowledge that the notes would be re-audited in 2 years.
The time allocated to the project was one half day a week during which time, on average, 20 case records were reviewed. With time for data processing and preparing presentations for each practice the first part of the audit cycle was completed in approximately 15 months (December 2001 -March 2003 .
With the introduction of the template, a download was taken at the time of audit as a baseline. This will be repeated on a yearly basis to measure any change which occurs. We plan to measure the impact of the educational intervention but interpretation of change may be confounded by the impact of new contract (accepted June 2003, implemented April 2004).
Statistics were analysed using Statsdirect computer software, using x 2 and proportional x 2 analysis. Confidence levels (CL) are 95%.
Results
The 610 patients (324 male, 286 female) of all ages, within a population of 99,924, indicate a prevalence of 0.6%. Two hundred and fifty (41%) had seen their GP concerning their epilepsy during the previous year. Furthermore, review rates varied significantly (range 7-79%) between practices (Fig. 1) . Practice 2 is the author's practice.
Of 138 (22%) patients nominally receiving shared care, 59 had attended the hospital clinic only. Therefore, 301 (49%) had not seen any doctor concerning their epilepsy in the previous year.
While all 41 children of 16 years or younger were attending paediatric clinics, only 97 adults had been reviewed in hospital clinic. If we assume that 30% of patients have a refractory condition, then a maximum of 97/171 (57%) of adults with drug-resistant epilepsy who should be under shared care are receiving this service (Table 2) .
When considering patterns of follow-up in primary care, 116 (19%) (CL 5.9-28.9%) were being reviewed regularly, i.e. at least yearly (Fig. 2) , 84 (14%) were being reviewed opportunistically and 410 (67%) (CL 55.5-83.0%) had no formal review pattern. Furthermore, 264 (43%) had not been reviewed by the GP for more than 2 years.
Diagnostic doubt was expressed in 67 (11%) cases (CL 6.2-13.4%). Uncertain diagnoses were more likely to have been made by a general physician ( p = 0.0032) and less likely by a paediatrician ( p < 0.0001).
The development of a city-wide epilepsy register 95 Figure 1 Variation in proportion of patients reviewed in last year by practice. Only 178 (29%) (CL 20.0-36.6%) patients were in documented remission, with a peak of 62% in one practice (Fig. 3) .
In 84 (14%) (CL 9.6-17.4) of the patients, there was unequivocal evidence of non-compliance with prescribed medication. This group was predominately male (m:f, 60:24) ( p = 0.0003). They were no less likely to have uncertain diagnosis, to have attended casualty or been admitted to hospital or to have been reviewed in the last year. They were less likely to be reviewed regularly ( p = 0.017). Ten of the men but no women had significant alcohol or drug abuse in their histories.
There were 107 women of child-bearing age (16-50 years) on treatment of which 37 were receiving sodium valproate, 6 of whom had evidence of partial seizures.
All four patients on vigabatrin were under followup by ophthalmologists.
A summary of the findings is illustrated in Table 3 .
Discussion
This project fulfilled its dual aims of quantifying the documented process of care of patients with epilepsy (PWE) across a city and providing every GP with an individualised template for each patient to facilitate review in the community and communication with secondary care. Our methods were well received within participating practices and could be widely replicated.
Audit findings
The most striking finding was the inadequate review arrangements. No practice achieved a 90% review rate while four practices failed to achieve the 25% review rate, which is the minimum quality standard in the proposed new contract. Our estimate that only 57% of adults with refractory epilepsy were receiving shared care is a matter of particular concern. The low remission rate (29%) is, probably, an artefact of poor documentation. However, in the absence of records we cannot be certain. There is evidence that patients with poorly controlled epilepsy may be reluctant to access services 14 and poor record keeping precludes accurate estimation of the number of these patients who are not being seen.
The rate of diagnostic uncertainty (11%) is similar to that described in other practice record reviews but lower than that reported in studies where patients have actually been assessed by specialists. 3 The observed non-compliance rate (14%) was consistent with previous reports. 15 Men predominate, 16% of whom have documented drug or alcohol problems. These individuals were identified because of 96 I. Minshall, D. Smith failure to pick up prescriptions, a fact which could be overlooked in a quick review appointment. The inclusion of a 'compliance' field in the template should prompt GPs to consider this important aspect of care.
A direct consequence of failure to review is doctors' lack of awareness of patients' knowledge about the management of their condition. This is of particular concern for young women taking potentially teratogenic compounds. Studies in both primary 16 and secondary care settings 17 concur in observing that many patients are uncertain about the necessity for long-term therapy. This, in turn, may contribute to poor or erratic compliance, which is a risk factor for epilepsy-related sudden death. 12 The epilepsy-related death audit showed there are some 800 deaths per year from epilepsy in the UK, some 40% of which may be preventable. 12 It identified the main problems with general practice as lack of timely access to skilled specialists, sparse evidence of structured management plans, triggers for referral were sometimes missed and professional communication failures. This audit describes a mechanism for overcoming these problems to improve local delivery of care to people with epilepsy.
Intervention and change
Prior to this audit, only 1 from 13 practices was systematically reviewing its patients with epilepsy. Our unique intervention facilitates this process. Every case record was thoroughly examined with key features included in the template. It remains the responsibility of individual GPs to assess their patients and act accordingly. Neither the prospect of re-audit nor the impending new contract compels a GP to act. However, each patient's template concludes with a clear recommendation. Even those doctors who choose to perform a cursory assessment should be able to reach a logical decision about management of each patient.
Conclusion
If our findings are a true reflection of the process of care of PWE in the community, then primary care faces an enormous task if it wants to ensure that all patients with epilepsy receive appropriate care in future. The CSAG report 1 recommends that each large practice should have a lead GP with an interest in epilepsy and these individuals could certainly facilitate change locally. However, this project has two distinct advantages over that proposal. Firstly, there was co-operation between interested representatives of primary and secondary care. Secondly, the PCT-appointed GP has produced a meaningful disease register for his/her colleagues, which facilitates the logical selection of patients for continued management in the community or referral for reassessment in specialist clinics.
